{"id":7247,"date":"2020-08-20T05:04:44","date_gmt":"2020-08-20T12:04:44","guid":{"rendered":"https:\/\/2020dev.rakuten-med.com\/?page_id=7247"},"modified":"2020-09-01T13:26:19","modified_gmt":"2020-09-01T20:26:19","slug":"our-future-outlook","status":"publish","type":"page","link":"https:\/\/rakuten-med.com\/us\/alluminox\/our-future-outlook\/","title":{"rendered":"Our Future Outlook"},"content":{"rendered":"
\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tOur Future Outlook\t\t\t\t\t\t<\/h1>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div><\/div><\/div><\/div>
\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tAbout Our Future Outlook\t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\tConquering cancer\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div>

\n
\n\t

Rakuten Medical first objective is to create and bring to market drugs and devices to treat cancer based on the Alluminox\u2122 platform by collaborating with premier cancer centers from around the world. This will lead to further advancing the development of new cancer therapies based on the technology platform.<\/p>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div>

\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tAlliance\t\t\t\t\t\t<\/h2>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div>
\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tStrategic Alliance\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div>
\n
\n\t

This strategic alliance aims to advance the development of new cancer therapies based on Alluminox\u2122 technology platform with institutions all over the world. Rakuten Medical and intuitions will collaborate to conduct studies based on the Alluminox\u2122 technology platform and to determine study designs, combination therapies, and target patient populations for future clinical trials. In May 2020, Rakuten Medical, Inc. and MD Anderson bound the strategic alliance agreement.<\/p>\n<\/div>\n<\/div><\/div>

\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tAlluminox\u2122 Alliance Institute\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div>
\n
\n\t

We established a cancer research alliance network program, the Alluminox\u2122 Alliance Institutes (IAI), in order to advance the development of new cancer therapies based on the Alluminox\u2122 platform. Rakuten Medical will expand the IAI network to include premier cancer centers from around the world.<\/p>\n<\/div>\n<\/div><\/div>

\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tInstitutions and principals of IAI\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div>
\n
\n\t

An institute as part of Alluminox\u2122 Alliance Institutes (IAI) has discussions with other premier cancer centers from around the world. IAI designates a lead principal who will act as an Alluminox\u2122 Advisor*.
\n*It depends on an institute to have an Alluminox\u2122 Advisor.<\/p>\n<\/div>\n<\/div><\/div>

\n\t\t\t\t\t\t\t

\n\t\t\t\t\t\tThe role of Alluminox\u2122 Advisor of IAI\t\t\t\t\t\t<\/h3>\n\t\t\t\t\t\t<\/div>\n<\/div><\/div>
\n
\n\t